MRK dividend yield: 3.25%. DGRO dividend yield: 2.19%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. DGRO focuses on US companies with a history of growing dividends, screening for payout ratio sustainability. With 500+ holdings and ultra-low 0.08% expense ratio, it offers broad diversification among dividend growers. One of BlackRock's most popular ETFs for long-term dividend growth investors.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
DGRO focuses on US companies with a history of growing dividends, screening for payout ratio sustainability. With 500+ holdings and ultra-low 0.08% expense ratio, it offers broad diversification among dividend growers. One of BlackRock's most popular ETFs for long-term dividend growth investors.
Is MRK or DGRO better for dividend income in 2026?
MRK currently offers a 3.25% yield (3.08/share/year) while DGRO offers 2.19% (1.28/share/year). MRK provides higher current income. However, DGRO has grown its dividend faster (9.5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs DGRO earn per year?
With $10,000 invested today: MRK pays approximately $325/year. DGRO pays approximately $219/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $653/year (DGRO).
Does MRK or DGRO pay monthly dividends?
MRK pays quarterly dividends. DGRO pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs DGRO comparison by email
Save your analysis + get weekly dividend insights. Free forever.